Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy

J Med Virol. 1983;12(3):179-86. doi: 10.1002/jmv.1890120303.

Abstract

The sera of 722 children and adolescents without overt liver disease were tested for hepatitis B surface antigen (HBsAg), antiHBs and anti-hepatitis B core anti-HBc; 658 of the sera were also tested for anti-hepatitis A virus anti-HAV. Except for the "passive" antibody peak observed in babies, the anti-HAV age-specific prevalence was negligible until the age of 3; it then increased, reaching 35% by the age of 15. Serological evidence of HBV was present in 16% of the subjects: this prevalence was almost constant at all ages. The HBsAg carrier rate was highest in children under 5 years of age (7.6%) and decreased with age. However, only one HBsAg carrier was under 1 year of age. Anti-HBs age-specific prevalence increased progressively from 2.7% to 11.4%. Anti-HBc alone was present in 4.1% of the subjects. No significant sex differences were found in the prevalence of HBV serum markers or in the HBsAg carrier rate. Neither HAV nor HBV infection was significantly influenced by place of residence or socioeconomic status. It is concluded that in this area both HAV and HBV are endemic, but while HAV is mainly acquired at school, most of the HBV infections occur within the household. The results suggest that not only perinatal transmission, but also intrafamilial horizontal infection, plays a role in HBV spread among infants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aging
  • Antibodies, Viral / analysis
  • Child
  • Child, Preschool
  • Female
  • Hepatitis A / epidemiology*
  • Hepatitis A Antibodies
  • Hepatitis B / epidemiology*
  • Hepatitis B Antibodies / analysis
  • Hepatitis B Surface Antigens / analysis
  • Humans
  • Infant
  • Infant, Newborn
  • Italy
  • Male
  • Rural Population
  • Sex Factors
  • Socioeconomic Factors
  • Urban Population

Substances

  • Antibodies, Viral
  • Hepatitis A Antibodies
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens